Your browser doesn't support javascript.
loading
Selective cytotoxicity of a novel mitochondrial complex I inhibitor, YK-135, against EMT-subtype gastric cancer cell lines due to impaired glycolytic capacity.
Sung, Yeojin; Cha, Seungbin; Kim, Sang Bum; Kim, Hakhyun; Choi, Seonghwi; Oh, Sejin; Kim, Minseo; Lee, Yunji; Kwon, Gino; Lee, Jooyoung; Lee, Joo-Youn; Han, Gyoonhee; Kim, Hyun Seok.
Affiliation
  • Sung Y; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Cha S; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim SB; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim H; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Choi S; Department of Integrated OMICS for Biomedical Sciences (WCU Program), Yonsei University, Seoul 03722, Korea.
  • Oh S; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kim M; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Lee Y; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Kwon G; Graduate Program for Nanomedical Science, Yonsei University, Seoul 03722, Korea.
  • Lee J; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722; Checkmate Therapeutics Inc., Seoul 07207, Korea.
  • Lee JY; Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea.
  • Han G; Department of Integrated OMICS for Biomedical Sciences (WCU Program), Yonsei University, Seoul 03722; Department of Biotechnology, Yonsei University, Seoul 03722, Korea.
  • Kim HS; Sevrance Biomedical Research Institute, Yonsei University College of Medicine, Seoul 03722; Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Checkmate Therapeutics Inc., Seoul 07207, Korea.
BMB Rep ; 55(12): 645-650, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36379512
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMB Rep Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMB Rep Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2022 Document type: Article Country of publication: